Early Discovery

Fueling scientific discovery

To accelerate intelligent & effective drug discovery processes, scientists worldwide have demanded greater levels of speed, efficiencies and depth of data from their LC-MS/MS solutions providers.

Fast Metabolic stability assessment for the identification of soft-spot analysis and the detection of low-level reactive metabolites have become indispensible tools in improving attrition rates, increasing the time to market and avoiding idiosyncratic adverse drug reactions down the road.

The uniquely intelligent workflows of the TripleTOF^TM 5600 and QTRAP® 5500 Systems enable fast and accurate metabolic stability screening and reactive metabolite (GSH-adduct)  detection.  High throughput screening workflows in the discovery lab have been reinvented through the automation, information sharing and advanced monitoring features of DiscoveryQuant^TM software allowing modern medicinal chemists to synthesize compounds at a rapid rate and helping early ADME/PK labs manage the increased demands for higher throughput and data quality.